New-Onset Diabetes in Covid-19
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19. These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
COVID ‐19 infection may cause ketosis and ketoacidosis
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 455
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
Chee, Y. J., Ng, S. J. H., & Yeoh, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108166 · Cited by 287
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Ren, H., Yang, Y., Wang, F., Yan, Y., Shi, X., Dong, K., Yu, X., & Zhang, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01035-2 · Cited by 200
Cited by
Items 101–200 of 808
Forde, R., Arente, L., Ausili, D., Backer, K. D., Due‐Christensen, M., Epps, A., Fitzpatrick, A., Grixti, M., Groen, S., Halkoaho, A., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14498 · Cited by 72
Mithal, A., Jevalikar, G., Sharma, R., Singh, A., Farooqui, K. J., Mahendru, S., Krishnamurthy, A., Dewan, A., & Budhiraja, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.029 · Cited by 77
Risk of Newly Diagnosed Diabetes After COVID-19 Infection: A Systematic Review and Meta-Analysis
Lai, H., Yang, M., Sun, M., Pan, B., Wang, Q., Wang, J., Tian, J., Ding, G., Yang, K., Song, X., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155330 · Cited by 73
State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease
Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70
“On the other hand, a diagnosis of COVID-19 has been associated with a higher risk for the development of both conditions, T2DM and dementia due to AD [26-28].”
BackgroundExpression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
Admin, A., Wijnant, S. R., Jacobs, M., Eeckhoutte, H. P. V., Lapauw, B., Joos, G. F., Bracke, K. R., & Brusselle, G. (2020) · Diabetes · doi:10.2337/db20-0669 · Cited by 75
Ghosh, A., Anjana, R. M., Rani, C. S. S., Rani, S. J., Gupta, R., Jha, A., Gupta, V. K., Kuchay, M. S., Luthra, A., Durani, S., et al. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.033 · Cited by 69
Brancaccio, M., Mennitti, C., Gentile, A., Correale, L., Buzzachera, C. F., Ferraris, C., Montomoli, C., Frisso, G., Borrelli, P., & Scudiero, O. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041502 · Cited by 69
Covid-19: re-opening universities is high risk
Yamey, G., & Walensky, R. P. (2020) · BMJ · doi:10.1136/bmj.m3365 · Cited by 75
CROMER, S. J., Colling, C., Schatoff, D., Leary, M., Stamou, M. I., Selen, D. J., Putman, M. S., & Wexler, D. J. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108145 · Cited by 68
Chen, M., Zhu, B., Chen, D., Hu, X., Xu, X., Shen, W., Hu, C., Li, J., & Qu, S. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.004 · Cited by 71
Qadir, M. M. F., Bhondeley, M., Beatty, W. L., Gaupp, D., Doyle‐Meyers, L. A., Fischer, T., Bandyopadhyay, I., Blair, R. V., Bohm, R. P., Rappaport, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151551 · Cited by 70
Vaccine rollout strategies: The case for vaccinating essential workers early
Mulberry, N., Tupper, P. F., Kirwin, E. M., McCabe, C. J., & Colijn, C. (2021) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000020 · Cited by 69
Magge, S. N., Wolf, R. M., Pyle, L. L., Brown, E. A., Benavides, V. C., Bianco, M. E., Chao, L. C., Cymbaluk, A., Balikcioglu, P. G., Halpin, K. L., et al. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.08.010 · Cited by 71
Mone, P., Gambardella, J., Wang, X., Jankauskas, S. S., Matarese, A., & Santulli, G. (2021) · Non-Coding RNA · doi:10.3390/ncrna7010009 · Cited by 68
Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection
Pant, A., Dsouza, L., & Yang, Z. (2021) · mBio · doi:10.1128/mbio.00635-21 · Cited by 75
Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID
Kim, Y., Kim, S. E., Kim, T., Yun, K. W., Lee, S. H., Lee, E. J., Seo, J.-W., Jung, Y. H., & Chong, Y. P. (2022) · Infection and Chemotherapy · doi:10.3947/ic.2022.0141 · Cited by 69
Patel, M. A., Knauer, M. J., Nicholson, M., Daley, M., Nynatten, L. R. V., Cepinskas, G., & Fraser, D. D. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00610-z · Cited by 69
Lu, J., Wilson, J., Hou, W., Fleysher, R., Herold, B. C., Herold, K. C., & Duong, T. Q. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104487 · Cited by 67
The association between COVID-19 and type 1 diabetes mellitus: A systematic review
Nassar, M., Nso, N., Baraka, B., Alfishawy, M., Mohamed, M., Nyabera, A., & Sachmechi, I. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.02.009 · Cited by 64
GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia
Wan, L., Gao, Q., Deng, Y., Ke, Y., Ma, E., Yang, H., Lin, H., Li, H., Yang, Y., Gong, J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-021-00508-2 · Cited by 64
Diabetes and COVID19: a bidirectional relationship
Ranjit Unnikrishnan, I., & Misra, A. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00163-2 · Cited by 63
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia
Zhou, W., Ye, S., Wang, W., Li, S., Hu, Q., & Masaki, T. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3918723 · Cited by 61
SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing
Nunn, A. V. W., Guy, G. W., Brysch, W., Botchway, S. W., Frasch, W. D., Calabrese, E. J., & Bell, J. D. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00204-x · Cited by 63
Rahmati, M., Yon, D. K., Lee, S. W., Udeh, R., McEvoy, M., Kim, M. S., Gyasi, R. M., Oh, H. Y., Sánchez, G. F. L., Jacob, L., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28833 · Cited by 64
Endocrine involvement in COVID-19: Mechanisms, clinical features, and implications for care
Garg, M., Gopalakrishnan, M., Yadav, P., & Misra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_440_20 · Cited by 59
Changes in Pediatric ICU Utilization and Clinical Trends During the Coronavirus Pandemic
Zee-Cheng, J. E., McCluskey, C. K., Klein, M. J., Scanlon, M. C., Rotta, A. T., Shein, S. L., Pineda, J. A., Remy, K. E., & Carroll, C. L. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.03.004 · Cited by 62
Dey, S., Murmu, N., Mondal, T., Saha, I., Chatterjee, S., Manna, R., Haldar, S., Dash, S. K., Sarkar, T. R., & Giri, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113801 · Cited by 65
New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination
Yano, M., Morioka, T., Natsuki, Y., Sasaki, K., Kakutani, Y., Ochi, A., Yamazaki, Y., Shoji, T., & Emoto, M. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9004-21 · Cited by 59
Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic
Chao, L. C., Vidmar, A. P., & Georgia, S. K. (2021) · Diabetes Care · doi:10.2337/dc20-2733 · Cited by 59
Early and late endocrine complications of COVID-19
Kazakou, P., Paschou, S. Α., Ψαλτοπούλου, Θ., Gavriatopoulou, M., Korompoki, E., Stefanaki, K., Kanouta, F., Kassi, G., Dimopoulos, M. A., & Mitrakou, A. (2021) · Endocrine Connections · doi:10.1530/ec-21-0184 · Cited by 59
Limited extent and consequences of pancreatic SARS-CoV-2 infection
van der Heide, V., Jangra, S., Cohen, P., Rathnasinghe, R., Aslam, S., Aydillo, T., Geanon, D., Handler, D., Kelley, G., Lee, B. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110508 · Cited by 60
Infections and diabetes: Risks and mitigation with reference to India
Unnikrishnan, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.022 · Cited by 58
Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management
Lau, D., & McAlister, F. A. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.11.001 · Cited by 53
Vitale, R. J., Valtis, Y. K., McDonnell, M. E., Palermo, N. E., & Fisher, N. D. L. (2020) · AACE Clinical Case Reports · doi:10.1016/j.aace.2020.11.019 · Cited by 57
COVID-19 induced Diabetes: A novel presentation
Joshi, S. C., & Pozzilli, P. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110034 · Cited by 56
The impact of covid-19 pandemic on pregnancy outcome
Gholami, R., Borumandnia, N., Kalhori, E., Taheri, M., & Khodakarami, N. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-06098-z · Cited by 55
Viswanathan, V., Puvvula, A., Jamthikar, A. D., Saba, L., Johri, A. M., Kotsis, V., Khanna, N. N., Dhanjil, S. K., Majhail, M., Misra, D. P., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i3.215 · Cited by 54
Izzo, R., Pacella, D., Trimarco, V., Manzi, M. V., Lombardi, A., Piccinocchi, R., Gallo, P., Esposito, G., Lembo, M., Piccinocchi, G., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102345 · Cited by 54
Phạm, Q., Gamble, A., Hearn, J., & Cafazzo, J. A. (2021) · Journal of Medical Internet Research · doi:10.2196/22320 · Cited by 56
Alfayez, O. M., Aldmasi, K. S., Alruwais, N. H., Awad, N. B., Yami, M. S. A., Almohammed, O. A., & Almutairi, A. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.856958 · Cited by 53
Makhoul, E., Aklinski, J. L., Miller, J., Leonard, C., Backer, S., Kahar, P., Parmar, M. S., & Khanna, D. (2022) · Cureus · doi:10.7759/cureus.27438 · Cited by 56
Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area
Verma, S., Lumba, R., Dapul, H. R., Simson, G. G., Phoon, C. K. L., Lighter, J., Farkas, J. S., Vinci, A., Noor, A., Raabe, V., et al. (2020) · Hospital Pediatrics · doi:10.1542/hpeds.2020-001917 · Cited by 52
Gentile, S., Strollo, F., Mambro, A., & Ceriello, A. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14170 · Cited by 52
COVID-19 as a trigger for type 1 diabetes
Wang, Y., Guo, H., Wang, G., Zhai, J., & Du, B. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad165 · Cited by 50
Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism
Umesh, A., Pranay, K., Pandey, R. C., & Gupta, M. K. (2022) · Infection · doi:10.1007/s15010-022-01835-6 · Cited by 52
Mechanisms of COVID-19 pathogenesis in diabetes
Narasimhulu, C. A., & Singla, D. K. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00204.2022 · Cited by 53
Masuda, R., Lodge, S., Nitschke, P., Spraul, M., Schaefer, H., Bong, S.-H., Kimhofer, T., Hall, D., Loo, R. L., Bizkarguenaga, M., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00458 · Cited by 53
Ballout, R. A., Kong, H., Sampson, M. L., Otvos, J. D., Cox, A. L., Agbor-Enoh, S. T., & Remaley, A. T. (2021) · Biomedicines · doi:10.3390/biomedicines9091090 · Cited by 50
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
Pathangey, G., Fadadu, P., Hospodar, A. R., & Abbas, A. E. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00259.2020 · Cited by 51
Type 1 diabetes mellitus following COVID‐19 RNA‐based vaccine
Sakurai, K., Narita, D., Saito, N., Ueno, T., Sato, R., Niitsuma, S., Takahashi, K., & Arihara, Z. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13781 · Cited by 50
Farrar, D. S., Drouin, O., Hepburn, C. M., Baerg, K., Chan, K. J., Cyr, C., Donner, E. J., Embree, J. E., FARRELL, C. A., Forgie, S. E. D., et al. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100337 · Cited by 46
COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes
Anand, A. V., Sangeetha, T., Fathah, Z., Pavithra, R., Sanjeev, A. M. A., Babu, S., Meyyazhagan, A., Yatoo, M. I., Sharun, K., Tiwari, R., et al. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.3.01 · Cited by 49
Amini‐Farsani, Z., Yadollahi‐Farsani, M., Arab, S., Forouzanfar, F., Yadollahi, M., & Asgharzade, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108071 · Cited by 48
Silverii, G. A., Monami, M., Cernigliaro, A., Vigneri, E., Guarnotta, V., Scondotto, S., Allotta, V. A., Conti, M., Giordano, C. S. D. S., & Mannucci, E. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.09.028 · Cited by 44
COVID-19: Diabetes Perspective—Pathophysiology and Management
Dallavalasa, S., Tulimilli, S. V., Janhavi, P., Ramachandra, R., Madhunapantula, S. V., & Veeranna, R. P. (2023) · Pathogens · doi:10.3390/pathogens12020184 · Cited by 47
COVID-19 Vaccine and Hyperosmolar Hyperglycemic State
Abu-Rumaileh, M. A., Gharaibeh, A., & Gharaibeh, N. E. (2021) · Cureus · doi:10.7759/cureus.14125 · Cited by 45
Diabetic Ketoacidosis and Mortality in COVID-19 Infection
Stevens, J. S., Bogun, M. M., McMahon, D. J., Zucker, J. E., Kurlansky, P. A., Mohan, S., Yin, M. T., Nickolas, T. L., & Pajvani, U. B. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101267 · Cited by 46
Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology
Gardner, G., & Fraker, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722979 · Cited by 46
Babar, M., Jamil, H., Mehta, N., Moutwakil, A., & Duong, T. Q. (2024) · Diagnostics · doi:10.3390/diagnostics14060621 · Cited by 50
Kamrath, C., Rosenbauer, J., Tittel, S. R., Warncke, K., Hirtz, R., Denzer, C., Dost, A., Neu, A., Pacaud, D., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-2791 · Cited by 47
Case Report: COVID-19 and Chagas Disease in Two Coinfected Patients
Alberca, R. W., Yendo, T. M., Ramos, Y. Á. L., Fernandes, I. G., Oliveira, L. D. M., Teixeira, F. M. E., Beserra, D. R., de Oliveira, E. A., Gozzi-Silva, S. C., Andrade, M. M. D. S., et al. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-1185 · Cited by 42
D’Errico, S., Zanon, M., Montanaro, M., Radaelli, D., Sessa, F., Mizio, G. D., Montana, A., Corrao, S., Salerno, M., & Pomara, C. (2020) · Microorganisms · doi:10.3390/microorganisms8111642 · Cited by 44
4,4′-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor
Lee, J., An, H. K., Sohn, M.-G., Kivela, P. D., & Oh, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175953 · Cited by 48
New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry
Papachristou, S., Stamatiou, I., Stoian, A. P., & Παπάνας, Ν. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00988-7 · Cited by 42
Haghpanah, A., Masjedi, F., Salehipour, M., Hosseinpour, A., Roozbeh, J., & Dehghani, A. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00388-3 · Cited by 43
Fath, M. K., Jahangiri, A., Ganji, M., Sefid, F., Payandeh, Z., Hashemi, Z. S., Pourzardosht, N., Hessami, A., Mard‐Soltani, M., Zakeri, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705772 · Cited by 42
New onset COVID-19–related diabetes: an indicator of mortalityPreprint
Yang, J., Jin, J., Liu, S., Bai, P., He, W., Wu, F., Liu, X., Chai, Z., & Han, D. (2020) · medRxiv · doi:10.1101/2020.04.08.20058040 · Cited by 43
Self-citationThe Multisystem Impact of Long COVID: A Comprehensive Review
Negruţ, N., Menegas, G., Kampioti, S., Bourelou, M., Kopanyi, F., Hassan, F. D., Asowed, A., Taleouine, F. Z., Ferician, A. C., & Marian, P. (2024) · Diagnostics · doi:10.3390/diagnostics14030244 · Cited by 46
Ilias, Ι., Diamantopoulos, A., Pratikaki, M. E., Botoula, E., Jahaj, E., Athanasiou, N., Tsipilis, S., Zacharis, A., Vassiliou, A. G., Vassiliadi, D. A., et al. (2021) · Medicina · doi:10.3390/medicina57010068 · Cited by 40
Mortality is not increased in SARS‐CoV‐2 infected persons with hepatitis C virus infection
Butt, A. A., Peng, Y., Chotani, R. A., & Shaikh, O. S. (2021) · Liver International · doi:10.1111/liv.14804 · Cited by 40
Hypovitaminosis D and the endocrine phenotype of COVID-19
Giustina, A. (2021) · Endocrine · doi:10.1007/s12020-021-02671-8 · Cited by 42
Nersesjan, V., Amiri, M., Christensen, H., Benros, M. E., & Kondziella, D. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.598272 · Cited by 43
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19
Sun, Z., He, G., Huang, N., Thilakavathy, K., Lim, J. C. W., Kumar, S. S., & Xiong, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707205 · Cited by 46
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Wong, R., Lam, E., Bramante, C. T., Johnson, S., Reusch, J. E. B., Wilkins, K. J., & Yeh, H. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01515-1 · Cited by 39
Xiong, X., Lui, D. T. W., Chung, M. S. H., Au, I. C. H., Lai, F. T. T., Wan, E. Y. F., Chui, C. S. L., Li, X., Cheng, F. W. T., Cheung, C., et al. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004274 · Cited by 41
Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series
Alsadhan, I., Alruwashid, S., Alhamad, M., Alajmi, S., Alshehri, S. M., Alfadhli, E. M., & Ekhzaimy, A. A. (2020) · Current Therapeutic Research · doi:10.1016/j.curtheres.2020.100609 · Cited by 37
Fisiopatología de la enfermedad COVID-19
MANTA, B., Sarkisian, A. G., FONTANA, B. G., & PRADO, V. P. (2022) · Odontoestomatología · doi:10.22592/ode2022n39e312 · Cited by 55
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
Sun, B., Huang, S., & Zhou, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592439 · Cited by 39
COVID-19 and hyperglycemia/diabetes
Michalakis, K. G., & Ilias, Ι. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i5.642 · Cited by 44
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
Rey‐Reñones, C., Martínez‐Torres, S., Martín‐Luján, F., Pericas, C., Redondo, A., Vilaplana-Carnerero, C., Domínguez, Á., & Grau, M. (2022) · Biomedicines · doi:10.3390/biomedicines10092089 · Cited by 41
Ricordi, C., Pacifici, F., Lanzoni, G., Palamara, A. T., Garaci, E., & Della‐Morte, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063134 · Cited by 36
Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
Simoneau, C. R., & Ott, M. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.11.012 · Cited by 37
Long-COVID, Metabolic and Endocrine Disease
Bornstein, S. R., Cozma, D., Kamel, M., Hamad, M. A., Mohammad, M. G., Khan, N. A., Saber-Ayad, M. M., Semreen, M. H., & Steenblock, C. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1878-9307 · Cited by 38
Self-citationChourasia, P. K., Goyal, L., Kansal, D., Roy, S., Singh, R., Mahata, I., Sheikh, A. B., & Shekhar, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031159 · Cited by 38
Xu, A., Wang, S. H., & Duong, T. Q. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003257 · Cited by 38
Buetti, N., Trimboli, P., Mazzuchelli, T., Priore, E. L., Balmelli, C., Trkola, A., Conti, M., Martinetti, G., Elzi, L., Ceschi, A., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02465-4 · Cited by 35
Animal models for SARS‐CoV‐2 infection and pathology
Bi, Z., Hong, W., Yang, H. J., Lu, S., & Peng, X. (2021) · MedComm · doi:10.1002/mco2.98 · Cited by 36
Emerging spectrum of post-COVID-19 syndrome
Kunal, S., Madan, M., Tarke, C., Gautam, D. K., Kinkar, J. S., Gupta, K., Agarwal, R., Mittal, S., & Sharma, S. M. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-139585 · Cited by 36
Wolf, R. M., Noor, N., Izquierdo, R. E., Jett, D., Rewers, A. H., Majidi, S., SHEANON, N. M., Breidbart, E., Demeterco‐Berggren, C., Lee, J. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13328 · Cited by 37
Gerganova, A., Assyov, Y. S., & Kamenov, Z. A. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.826006 · Cited by 39
Enteroviruses and T1D: Is It the Virus, the Genes or Both which Cause T1D
Geravandi, S., Liu, H., & Maedler, K. (2020) · Microorganisms · doi:10.3390/microorganisms8071017 · Cited by 36
Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients
Ilias, Ι., Jahaj, E., Kokkoris, S., Zervakis, D. I., Temperikidis, P., Magira, E. E., Pratikaki, M. E., Vassiliou, A. G., Routsi, C., Kotanidou, Α., et al. (2020) · In Vivo · doi:10.21873/invivo.12136 · Cited by 33
ACE2 function in the pancreatic islet: Implications for relationship between SARS‐CoV‐2 and diabetes
Memon, B., & Abdelalim, E. M. (2021) · Acta Physiologica · doi:10.1111/apha.13733 · Cited by 38
Sindemia, infodemia, pandemia de COVID-19: Hacia una pandemiología de enfermedades emergentes
Filho, N. D. A. (2021) · Salud Colectiva · doi:10.18294/sc.2021.3748 · Cited by 43
Bruscoli, S., Puzzovio, P. G., Zaimi, M., Tiligada, K., Levi‐Schaffer, F., & Riccardi, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106511 · Cited by 35
Soluble HLA-G is upregulated in serum of patients with severe COVID-19
Al-Bayatee, N. T., & Ad'hiah, A. H. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.07.007 · Cited by 32
Sousa, B. L. A., Brentani, A., Ribeiro, C. C. C., Dolhnikoff, M., Grisi, S. J. F. E., Ferrer, A. P. S., & Ferraro, A. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050724 · Cited by 34
Newly-onset type 1 diabetes mellitus precipitated by COVID-19 in an 8-month-old infant.
Soliman, A. T., Al-Amri, M., Alleethy, K., Alaaraj, N., Hamed, N., & Sanctis, V. D. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10074 · Cited by 31
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Faist, A., Janowski, J., Kumar, S., Hinse, S., Çalışkan, D. M., Lange, J., Ludwig, S., & Brunotte, L. (2022) · Cells · doi:10.3390/cells11142198 · Cited by 32
SARS-CoV-2 and male infertility: from short- to long-term impacts
Dai, P., Qiao, F., Chen, Y.-S. E., Chan, D. Y. L., Yim, H. C. H., Fok, K. L., & Chen, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02055-x · Cited by 33
Metadata
- Authors
- Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E.
- Affiliations
- King's College London (GB)
- Monash University (AU)
- Imperial College London (GB)
- Technische Universität Dresden (DE)
- University of Colorado Anschutz (US)
- Agostino Gemelli University Polyclinic (IT)
- Nanyang Technological University (SG)
- University of Pisa, Pisa, Italy
- Peking University (CN)
- Kings Health Partners (GB)
- University of Michigan (US)
- University of Leicester (GB)
- Université de Yaoundé I (CM)
- University of Montpellier, Montpellier, France
- Corresponding author
- Rubino, Francesco
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-08-20
- Volume
- 383
- Issue
- 8
- Pages
- 789-790
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7304415
- OpenAlex
- W3035586023
- Cited by
- 801
- References
- 5
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 58 · 2023: 112 · 2022: 199 · 2021: 258 · 2020: 124
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Transcampus of Technische Universität Dresden & King’s College London
- King’s College London, London, UK and Monash University, Melbourne Australia
- Institute of Diabetes, Endocrinology, Obesity, King’s Health Partners
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- new-onset diabetes, COVID-19 pandemic, diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe COVID-19, insulin therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Diabetes Mellitus, Glucose, Humans, Pneumonia, Viral, Registries, Global Health, Coronavirus Infections, Diabetes Complications, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.